MXRA5 has also been described to be a promising marker of early tissue injury and fibrosis (19), and its application has been extensively investigated in experimental studies of myocardial damage, kidney cancer, and chronic kidney disease (19, 30). Here, MXRA5 is linked to kidney cancer.